Genome-wide meta-analysis, fine-mapping, and integrative prioritization identify new Alzheimer’s disease risk genes
View ORCID ProfileJeremy Schwartzentruber, Sarah Cooper, View ORCID ProfileJimmy Z Liu, View ORCID ProfileInigo Barrio-Hernandez, Erica Bello, View ORCID ProfileNatsuhiko Kumasaka, Toby Johnson, Karol Estrada, View ORCID ProfileDaniel J. Gaffney, View ORCID ProfilePedro Beltrao, View ORCID ProfileAndrew Bassett
doi: https://doi.org/10.1101/2020.01.22.20018424
Jeremy Schwartzentruber
1European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Cambridge, UK
2Open Targets, Wellcome Genome Campus, Cambridge, UK
Sarah Cooper
2Open Targets, Wellcome Genome Campus, Cambridge, UK
3Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK
Jimmy Z Liu
4Biogen, Cambridge, MA, 02142, USA
Inigo Barrio-Hernandez
1European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Cambridge, UK
2Open Targets, Wellcome Genome Campus, Cambridge, UK
Erica Bello
2Open Targets, Wellcome Genome Campus, Cambridge, UK
3Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK
Natsuhiko Kumasaka
3Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK
Toby Johnson
5Target Sciences-R&D, GSK Medicines Research Centre, Stevenage, UK
Karol Estrada
6BioMarin Pharmaceutical, San Rafael, CA 94901, USA
Daniel J. Gaffney
2Open Targets, Wellcome Genome Campus, Cambridge, UK
3Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK
7Genomics Plc, Oxford, OX1 1JD, UK
Pedro Beltrao
1European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Cambridge, UK
2Open Targets, Wellcome Genome Campus, Cambridge, UK
Andrew Bassett
2Open Targets, Wellcome Genome Campus, Cambridge, UK
3Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK
Data Availability
Genome-wide summary statistics will be made available through the NHGRI-EBI GWAS catalog upon publication.
Posted January 27, 2020.
Genome-wide meta-analysis, fine-mapping, and integrative prioritization identify new Alzheimer’s disease risk genes
Jeremy Schwartzentruber, Sarah Cooper, Jimmy Z Liu, Inigo Barrio-Hernandez, Erica Bello, Natsuhiko Kumasaka, Toby Johnson, Karol Estrada, Daniel J. Gaffney, Pedro Beltrao, Andrew Bassett
medRxiv 2020.01.22.20018424; doi: https://doi.org/10.1101/2020.01.22.20018424
Genome-wide meta-analysis, fine-mapping, and integrative prioritization identify new Alzheimer’s disease risk genes
Jeremy Schwartzentruber, Sarah Cooper, Jimmy Z Liu, Inigo Barrio-Hernandez, Erica Bello, Natsuhiko Kumasaka, Toby Johnson, Karol Estrada, Daniel J. Gaffney, Pedro Beltrao, Andrew Bassett
medRxiv 2020.01.22.20018424; doi: https://doi.org/10.1101/2020.01.22.20018424
Subject Area
Subject Areas
- Addiction Medicine (354)
- Allergy and Immunology (678)
- Anesthesia (182)
- Cardiovascular Medicine (2678)
- Dermatology (227)
- Emergency Medicine (404)
- Epidemiology (12310)
- Forensic Medicine (10)
- Gastroenterology (769)
- Genetic and Genomic Medicine (4158)
- Geriatric Medicine (390)
- Health Economics (685)
- Health Informatics (2694)
- Health Policy (1010)
- Hematology (365)
- HIV/AIDS (861)
- Medical Education (401)
- Medical Ethics (110)
- Nephrology (444)
- Neurology (3931)
- Nursing (212)
- Nutrition (584)
- Oncology (2071)
- Ophthalmology (596)
- Orthopedics (243)
- Otolaryngology (307)
- Pain Medicine (253)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1131)
- Primary Care Research (461)
- Public and Global Health (6578)
- Radiology and Imaging (1420)
- Respiratory Medicine (876)
- Rheumatology (414)
- Sports Medicine (345)
- Surgery (455)
- Toxicology (54)
- Transplantation (189)
- Urology (169)